Background: Evidence from the United States and Europe suggests that the use of prescription drugs may vary by ethnicity. In Canada, ethnic disparities in prescription drug use have not been as well documented as disparities in the use of medical and hospital care. We conducted a cross-sectional analysis of survey and administrative data to examine needs-adjusted rates of prescription drug use by people of different ethnic groups.
F rom 1986 to 2006, as a result of their increased availability, promotion and use, prescription drugs became the fastest growing component of Canada's health care costs. 1 During that time, the ethnic composition of Canada's population changed substantially: the share of the population born outside Canada rose from 16% to 20%, and the share belonging to "visible minorities" increased from 6% to 16%. 2 Although ethnicity is a difficult construct to work with empirically, it an important marker of societal groupings for health care practice and policy. People of different ethnic identities may have different needs for, access to and even outcomes from health care. 3 Racial and ethnic disparities in the use of medical and hospital care have been documented in Canada and other developed countries; [4] [5] [6] [7] [8] however, disparities in prescription drug use have not been studied as thoroughly in Canada. Evidence from the United States and Europe suggests that prescription drug use may vary by race and country of birth, and Canadian studies have shown disparities between Aboriginal and non-Aboriginal populations. [9] [10] [11] [12] [13] [14] With regard to the growing non-Aboriginal ethnic minority groups in Canada, it may not be possible, for a number of reasons, to extrapolate existing evidence of disparities in the use of health services to disparities in the use of prescription drugs. Because outpatient pharmaceutical benefits are not universal in Canada, disparities in access to prescription drugs may exist even if access to primary care is relatively equitable. Moreover, ethnic differences in beliefs about pharmaceuticals could result in differences in the use of medicines that are not reflected in the use of other health services. 15 We compared the use of prescription drugs in a sample of residents of different ethnic backgrounds in the province of British Columbia. We studied the use of prescription drugs from 6 therapeutic classes: antihypertensives, oral antibiotics, antidepressants, statins, respiratory drugs and nonsteroidal anti-inflammatory drugs (NSAIDs). We chose these classes to reflect commonly used medicines (which was necessary to ensure sufficient statistical power in the analysis) that spanned a variety of therapeutic purposes. The latter criterion enabled us to explore the hypothesis that, owing to the influences of personal beliefs, ethnic variations in the use of prescription drugs will differ by the nature of treatment. Our ethnicity measure was based on responses to the CCHS question "People living in Canada come from many different cultural and racial backgrounds. Are you: ...?" Individuals could respond yes to any of 13 ethnic groups read to them. We coded individuals who responded yes to more than one ethnic group as being of mixed ethnicity; those who responded yes to a single ethnic group were assigned to one of the following categories: white; Chinese; South Asian; other Asian; or non-Asian, nonwhite. (See Appendix C, online, for details regarding ethnic groupings.) We also used the CCHS data to identify recent immigrants, whom we defined as respondents who immigrated to Canada within 10 years of 2005 (our observation year).
Methods
To measure health status, we constructed aggregated diagnostic groups (ADGs) and expanded diagnostic clusters (EDCs) based on International Classification of Diseases (ICD-9 and ICD-10) codes drawn from records of all fee-for-services medical visits and hospital discharges during 2005. 18 A higher count of ADGs indicates a greater degree of overall clinical complexity and is predictive of increased likelihood of prescription drug use. 19 EDCs denote the diagnosis of specific clinical conditions; we used EDCs to identify common indications for each of the drug classes studied (see Appendix B, online). The EDCs included in each model were selected by practising physicians and a clinical pharmacist for a previously published study of prescription drug use in British Columbia. 17 We used administrative records to construct household income quintiles based on a combination of household-specific and neighbourhood-level income data. 20 Evidence indicates that access to public drug benefits does not differ by ethnic group. 21 However, to adjust for possible differences in access to private insurance benefits, we identified all individuals living in households for which the family's provincial medical premiums were paid through a household member's employment. Such payment is an indicator of employment-related health benefits that often also include private drug coverage.
Statistical analysis.
We computed unweighted, sex-stratified multivariable logistic regressions on our outcome variables. Informed by models of health services utilization and evidence concerning prediction of pharmaceutical use and costs, our models included age, health status, income, employment-related health benefits and recent immigration (within 10 years). To allow for nonlinear relationships between age and the likelihood of filling prescriptions, we defined age using dummy variables for 10-year age groups. Findings concerning ethnic variations were robust to the inclusion or exclusion of variables that were not consistently statistically significant, namely employment-related health benefits and recent immigration. 
Results
The final sample for our study included 19 370 individuals (Table 1) . People who identified themselves as white were older, wealthier, less healthy and less likely to have recently immigrated to Canada than people who were of non-white ethnic backgrounds. Respondents of mixed ethnicity (85% of whom replied yes to "white" and a visible minority group) were younger, wealthier and less likely to be a recent immigrant than those of a single ethnic group.
Crude rates of diagnoses of conditions for which the selected drug classes are indicated varied by ethnic group, the largest variation being observed for diagnoses for which antidepressants are indicated. White women, white men and south Asian men had the highest sex-specific prevalence of conditions for which antihypertensives are commonly indicated. South Asian men had the highest prevalence of conditions for which antibiotics, statins, NSAIDs and respiratory drugs are commonly indicated. South Asian women had the highest prevalence of conditions for which antibiotics and NSAIDs are commonly indicated. Women who were in either the white or the non-Asian, non-white ethnic groups and men of mixed ethnicity had the highest prevalence of conditions for which antidepressants are commonly indicated. Crude rates of antihypertensive, antidepressant and statin use were highest among white women and men; crude rates of antibiotic and NSAID use were highest among South Asian women and men. Crude rates of respiratory drug use were highest among white women and South Asian men. After adjustment for age, general health status (using counts of ADGs), condition-specific indications (using specific EDCs), socioeconomic factors and recent immigration, several ethnic differences in the use of prescription drugs remained. 
Interpretation
Using linked survey and administrative data, we found statistically significant ethnic differences in the use of prescription drugs among non-Aboriginal residents in urban areas of British Columbia, even after adjusting for age, health status, socio-economic factors and recent immigration. Compared with respondents who were white, those who were South Asian or of mixed ethnicity were about as likely to fill prescriptions for most classes of medicines studied; however, South Asian men were significantly more likely to fill prescriptions for antibiotics and NSAIDs. Although a dominant pattern is difficult to determine because ethnic differences in presciption drug use appear to vary across therapeutic categories, there are nevertheless some important disparities. Chinese women were less likely than white women to fill prescriptions for antihypertensives, antibiotics, antidepressants and respiratory drugs. Chinese men were less likely than white men to fill prescriptions for statins and antidepressants. Overall, ethnic disparities were greater among women than among men, which suggests that gender roles, relationships and institutions may modify the effects of ethnicity on patient or provider behaviour.
Although rates of prescription drug use are lower in British Columbia than in other provinces, 22 we believe that the ethnic differences identified in our study are likely representative of disparities among ethnic populations in urban areas across Canada. Moreover, the results of our study are generally consistent with previous research from the United States and Europe, which showed that ethnic groups use prescription drugs less frequently than white people. [9] [10] [11] [12] Two findings from our study stand out from the literature on prescription drug use: the increased use of antibiotics by South Asian men compared with white men and the increased use of NSAIDs by South Asian woman and men compared with white women and men. However, there is evidence of a higher prevalence of reported pain among South Asian groups than among white people, which may explain these patterns. 23 Differences in the use of prescription drugs across ethnic groups may have resulted from differences in access to medical care, [4] [5] [6] [7] [8] burdens of illness, [24] [25] beliefs about medicines 15 or communications with practitioners. 26 The pattern of findings across the drug classes we studied suggests that some differences may stem from beliefs and preferences about the use of prescription drugs versus other treatment options (including herbal medicines). 27 We found the greatest degree of ethnic variation in the use of antidepressants, a drug class for which cultural beliefs about health and treatment are likely to affect patient choices. 15 Patients of different ethnic backgrounds who have depression or anxiety may present differently; immigrants to Canada may also choose to seek care through other sources, including importing medicines during visits to their country of birth. 28 It is potentially encouraging that differences in the use of antihypertensives and statins were smaller than differences in the use of other classes of drugs; nevertheless, there appear to be ethnic differences of potential clinical significance in such essential drug classes, particularly for Chinese people. The source of such differences may not be limited to patient preference: a telephone survey of residents in Vancouver (the largest urban area of British Columbia) found that Chinese immigrants to Canada were less likely than people of other ethnic backgrounds to receive patient education about heart disease from their health care providers. 26 Our study has limitations. Although we were able to link data on self-reported ethnic identities with administrative data on filled prescriptions, quantitative analysis of observational data can provide only a generalized account of the complex personal and social dimensions of ethnicity. 29 Our measure of prescription drug use was based on filled prescriptions, with no guarantee that the medicines were actually taken. Moreover, some prescriptions may not be filled by patients owing to cost, beliefs or other reasons. Some of the ethnic differences in the use of prescription drugs in our study may therefore have been due to differences in the rates of prescriptions filled by patients, not to differences in the rates of prescriptions written by practitioners. The use of administrative data also limits diagnostic information to that documented during encounters for medical and hospital services. Our methods may therefore understate the level of health care needs for groups who experience economic, cultural or other demonstrable barriers to health care. Given that our primary finding was that the use of prescription drugs was lower among ethnic minorities who may use fewer health services, the bias from underreporting health care needs would tend to understate the extent of needs-adjusted ethnic disparities.
Having pooled CCHS data across multiple years, we were unable to use information on self-reported health status and health care use from the survey, because such measures are not time-invariant. We were, however, able to link data on self-reported ethnicity to administrative health care data that are not subject to recall or socialdesirability bias that might otherwise affect measurement of health care needs and prescription drug use. The linkage of 3 cycles of the CCHS data to administrative records produced a sample that, despite having a higher percentage of ethnic minorities than samples of the CCHS used in other studies, 8 
Conclusion
Despite a relatively equitable system of health care financing in Canada, there appear to be significant ethnic differences in prescription drug use. Some of these differences, such as marked variation in the use of antidepressants, may reflect acceptable differences resulting from patient preferences and beliefs; others may reflect unacceptable inequities in quality of care and resulting outcomes. Further research is needed to separate the former from the latter. The differences in patterns of prescription drug use that we observed across ethnic groups suggest that simple comparisons between white people and a single "visible minority" group should be avoided whenever possible in future research. Moreover, our sex-specific findings suggest that gender and ethnicity interact in ways that are potentially important for health care practice and policy. To address these important issues with quality scientific evidence, more routine collection of, and research into, information concerning ethnicity and health care in Canada will be required.
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